Azurity Pharmaceuticals, Inc. Recalls

Overview of recall records associated with Azurity Pharmaceuticals, Inc., including dates, categories and classifications where available.

1recall records

Apr 12, 2023latest record date

Apr 12, 2023earliest record date

Recall history in this database

Classification mix: Class II: 1.

DrugApr 12, 2023

Testosterone Cypionate Injection, USP, CIII, 200 mg/mL recall — FDA D-0489-2023

cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.

Class IIFDA: TerminatedAzurity Pharmaceuticals, Inc.

Understanding this recall history

This page summarizes recall records in which the official source identifies Azurity Pharmaceuticals, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.